Has Rajiv Dhamija, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,222 in general payments to Rajiv Dhamija, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajiv Dhamija, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajiv Dhamija, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajiv Dhamija, MD

Nephrology · Artesia, CANPI 1396958955

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,027 of the $1,222 with a category attached, or 84.0%. It is spread thinly across 11 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $304 and has fallen 82.9% since, to $52 in 2025. That places this record below the midpoint for nephrology clinicians in CA, where the typical reported total is $1,018.

$1,222in general payments, 2019–2025

Across 22 payments — averaging $55.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$258
Otsuka America Pharmaceutical, Inc.$195
Baxter Healthcare$131
Amgen$125
GSK$120
Bard Peripheral Vascular, Inc.$97
plus $296 from 5 others

$3,500in research payments, 2019–2025

Across 2 payments — averaging $1750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GSK$4K

What the payments were for

Food & beverage$1,02784%
Education$19516%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	7	$258
Otsuka America Pharmaceutical, Inc.	3	$195
Baxter Healthcare	1	$131
Amgen	1	$125
GSK	1	$120
Bard Peripheral Vascular, Inc.	1	$97
Bayer	1	$87
Nxstage Medical, Inc.	2	$75
Fresenius USA Marketing, Inc.	3	$55
Abbott	1	$52
Ultragenyx Pharmaceutical Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,222 in reported general payments places this provider in the 50th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California →

Medicare billing

Part B allowed, 2024

$36,318

Medicare patients

Services billed

119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sevelamer Carbonate	37	$16,223
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	11	$4,521
Calcium Acetate	14	$796
Gabapentin	21	$229
Levothyroxine Sodium	14	$199
Furosemide	24	$168
Hydralazine Hcl	11	$152
Lisinopril	39	$144
Allopurinol	17	$97
Atorvastatin Calcium	11	$89
Amlodipine Besylate	36	$89
Simvastatin	11	$62
Clonidine Hcl	16	$47
Hydrochlorothiazide	11	$34
Tramadol Hcl	12	$13

Paid to pharmacies, not to this prescriber.

Other nephrology in Artesia

Anjay RastogiLos Angeles$2.2M
Glenn ChertowStanford$2M
Luis AlvarezPalo Alto$1.8M
Jose MorfinSacramento$1M
Rodolfo BatarseRancho Mirage$910K
Vandana MathurWoodside$769K
Yasir QaziOrange$618K
Rafael VillicanaLoma Linda$610K
Sunil PatelApple Valley$509K
Suphamai BunnapradistLos Angeles$498K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →